ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 1187

$635K Total Retail Price of All Prescriptions

Rank: 102 out of 1187

702 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 702 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 702 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,206 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 525 514 1 3
FUROSEMIDE 412 399 2 8
AMLODIPINE BESYLATE 269 266 3 2
SIMVASTATIN 259 242 4 1
OMEPRAZOLE 256 234 5 5
METOPROLOL TARTRATE 255 224 6 10
DONEPEZIL HCL 239 239 7 26
NAMENDA 229 229 8 44
WARFARIN SODIUM 227 221 9 13
OXYCODONE-ACETAMINOPHEN 225 204 S2 10 47
RISPERIDONE 209 209 11 58
FENTANYL 201 185 S2 12 82
QUETIAPINE FUMARATE 172 172 13 75
DIGOXIN 162 162 14 65
FAMOTIDINE 154 141 15 48
GABAPENTIN 149 132 16 23
SERTRALINE HCL 148 142 17 22
PREDNISONE 145 145 18 61
CLOPIDOGREL 140 139 19 33
METFORMIN HCL 128 97 20 7
CITALOPRAM HBR 127 126 21 45
POLYETHYLENE GLYCOL 3350 116 116 22 86
METOPROLOL SUCCINATE 102 100 23 11
NEXIUM 100 100 24 15
CARVEDILOL 98 98 25 19
HYDROCHLOROTHIAZIDE 98 91 25 9
LIDODERM 97 95 27 80
ENALAPRIL MALEATE 97 89 27 27
DIOVAN 95 95 29 17
POTASSIUM CHLORIDE 94 94 30 32
ZOLPIDEM TARTRATE 91 77 31 14
ESCITALOPRAM OXALATE 91 87 31 51
PLAVIX 89 89 33 52
PANTOPRAZOLE SODIUM 86 86 34 42
LISINOPRIL 84 79 35 4
DILTIAZEM 24HR CD 79 79 36 131
GLIPIZIDE 78 77 37 71
LEVETIRACETAM 77 73 38 89
LOSARTAN POTASSIUM 77 70 38 21
NITROGLYCERIN PATCH 71 71 40 138
VENLAFAXINE HCL ER 69 69 41 121
ATORVASTATIN CALCIUM 63 63 42 6
NOVOFINE AUTOCOVER 60 60 43 372
MIRTAZAPINE 59 59 44 54
OXYCODONE HCL 59 20 S2 44 38
HYDROCODONE-ACETAMINOPHEN 59 46 S3 44 20
PAROXETINE HCL 58 53 47 81
CARBIDOPA-LEVODOPA 57 57 48 99
ACETAMINOPHEN-CODEINE 57 56 S3 48 105
TAMSULOSIN HCL 57 57 48 29
OXYCONTIN 56 30 S2 51 76
KLOR-CON M20 56 56 51 93
LEVOFLOXACIN 55 50 53 74
SPIRONOLACTONE 53 47 54 98
JANUVIA 53 53 54 34
EXELON 50 50 56 132
MEGESTROL ACETATE 50 50 R 56 185
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.